Pharmaceutical News Headlines For May 21 2012 ( Monday )


• Let the Dealmaking for AstraZeneca PLC (AZN) Begin! More...

• Auxilium Pharmaceuticals (AUXL), GlaxoSmithKline (GSK) Strikes Pact to Co-promote Testim® in the U.S. More...

• Xiangxue Pharmaceutical to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory More...

• Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) and Girindus Announce Strategic Alliance More...

• Provence Technologies and Neuroptis Biotech Partner to Develop a New Compound for Treating Dry Eye Syndrome More...

• Cancer Genetics, Inc. Delays IPO to Avoid Faceoff with Facebook More...

• BioTime (BTX) Completes Merger of XenneX, Inc. into LifeMap Sciences, Inc. More...

• Pfizer Inc. (PFE) Rep: I Was Fired for Being Pregnant More...

• GenVec Inc. (GNVC) Appoints Cynthia Collins as President and CEO More...

• iPierian Inc. Appoints Pamela B. Conley as Vice President of Research More...

• Biostem U.S. Corporation (BOSM) Adds Jeanne Ann Lumadue, MD, PhD, MBA to Its Scientific and Medical Board of Advisors More...

• China Nuokang Bio-Pharmaceutical Inc. (NKBP) Forms Independent Committee and Appoints Independent Legal Counsel to Evaluate "Going Private" Proposal More...

• DARA BioSciences, Inc. Reports Financial Results for the First Quarter 2012 and Provides Key Highlights of the Company's Business Milestonesd More...

• First China Pharma (FCPG.OB) Announces Unaudited Financials and Issues Guidance for Q1 2012 More...

• Taro Pharmaceutical Industries Ltd. (TARO) to Announce Financial Results for the Quarter Ended March 31, 2012 More...

• Johnson & Johnson (JNJ) Successfully Sues Chinese Distributor for Breach More...

• Missing Data Raise Doubts on Johnson & Johnson (JNJ) Drug: FDA Staff More...

• Apricus Biosciences (APRI) Granted Regulatory Meeting With FDA for Femprox® for the Treatment of Female Sexual Arousal Disorder More...

• Cellceutix (CTIX) Files Amended IND With FDA for Its Novel p53 More...

• Pfizer Inc. (PFE) Recalls 650,000 Bottles of Advil Liqui-Gels More...

• Perrigo Company (PRGO) Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules More...

• Peregrine Pharmaceuticals, Inc. (PPHM) Reports Positive Top-Line Data From Bavituximab Phase II Trial More...

• SLA Pharma AG Reports Successful Phase 3 Results for Treatment of Anal Fissure More...

• Helix Biopharma (CC:HBP) Receives Regulatory Approval to Conduct a European Phase III Clinical Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions More...

• 600 Patients Recruited in Active Biotech AB (BTPC)'s and Ipsen's Tasquinimod Clinical Phase III Study More...

• Nymox Pharmaceutical (NYMX) Release: New Positive Data on NX-1207 Presented at Symposium and Panel Discussion at American Urological Association Annual Meeting More...

• Red Meat and Butter "Could Raise Alzheimer's Risk," Harvard University Study More...

• Folic Acid May Reduce Some Childhood Cancers, Washington University in St. Louis Study More...

• Oxytocin Improves Brain Function in Children With Autism, Yale University School Of Medicine Sudy More...

• Research With Dogs Points to Early Test for Arthritis, University of Missouri Study More...

• Precision Therapeutics, Inc. Release: Three Abstracts on the ChemoFxĂ‚® Drug Response Marker Accepted by American Society of Clinical Oncology More...

• Aegis Therapeutics, LLC Awarded Patent for Octreotide Formulations Suitable for Oral and Metered Nasal Spray Delivery More...

• Rockwell Medical Technologies (RMTI) Announces European Patent Issuance for Proprietary SFP Formulation More...

• Ranbaxy Laboratories (RANBAXY.BO) Plans to Relaunch Skin Drug in the US More...

• Merck & Co., Inc. (MRK) Says FDA Approved Labeling Update for ISENTRESS More...

• Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules More...

• Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets) More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply